ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 93 filers reported holding ADMA BIOLOGICS INC in Q2 2021. The put-call ratio across all filers is 5.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $671,608 | -3.0% | 187,600 | 0.0% | 0.00% | – |
| Q2 2023 | $692,244 | +88.1% | 187,600 | +68.7% | 0.00% | – |
| Q1 2023 | $368,072 | -14.7% | 111,200 | 0.0% | 0.00% | – |
| Q4 2022 | $431,456 | +285.2% | 111,200 | +141.7% | 0.00% | – |
| Q3 2022 | $112,000 | +124.0% | 46,000 | +82.5% | 0.00% | – |
| Q2 2022 | $50,000 | -65.3% | 25,200 | -69.3% | 0.00% | – |
| Q1 2021 | $144,000 | -10.6% | 82,000 | -0.8% | 0.00% | – |
| Q4 2020 | $161,000 | -37.8% | 82,700 | -23.8% | 0.00% | – |
| Q3 2020 | $259,000 | -52.2% | 108,500 | -41.3% | 0.00% | – |
| Q2 2020 | $542,000 | +107.7% | 184,900 | +104.3% | 0.00% | – |
| Q1 2020 | $261,000 | +177.7% | 90,500 | +283.5% | 0.00% | – |
| Q4 2019 | $94,000 | -10.5% | 23,600 | 0.0% | 0.00% | – |
| Q3 2019 | $105,000 | +15.4% | 23,600 | 0.0% | 0.00% | – |
| Q2 2019 | $91,000 | – | 23,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Biomark Capital Management Co. LLC | 1,433,304 | $4,415,000 | 5.01% |
| Aisling Capital LLC | 3,608,171 | $11,113,000 | 1.83% |
| Iguana Healthcare Management, LLC | 1,130,000 | $3,480,000 | 0.96% |
| Consonance Capital Management LP | 1,273,933 | $3,924,000 | 0.43% |
| Perceptive Advisors | 1,442,204 | $4,442,000 | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 39,000 | $120,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 11,673 | $36,000 | 0.00% |
| Renaissance Technologies | 20,300 | $63,000 | 0.00% |
| ROYAL BANK OF CANADA | 2 | $0 | 0.00% |
| VANGUARD GROUP INC | 311,514 | $960,000 | 0.00% |